Download PDF
Diabetologie und Stoffwechsel 2018; 13(02): 174-183
DOI: 10.1055/a-0576-6497
Originalarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Praxisbezogene Empfehlungen zum Ambulanten Glukoseprofil

Practical Recommendations for the Ambulatory Glucose Profile
Jens Kroeger
1   Zentrum für Diabetologie Hamburg-Bergedorf, Hamburg
,
Andreas Reichel
2   Medizinische Klinik III Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden
,
Thorsten Siegmund
3   Diabetes-, Hormon- und Stoffwechselzentrum am Isarklinikum, München
,
Ralph Ziegler
4   Diabetologische Schwerpunktpraxis für Kinder und Jugendliche, Münster
› Author Affiliations
Further Information

Publication History

14 January 2018

14 February 2018

Publication Date:
04 May 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Kontinuierliches Glukosemonitoring resultiert in großen Datenmengen, die mithilfe des Ambulanten Glukoseprofils (AGP) standardisiert zusammengefasst und grafisch dargestellt werden können. Das AGP ermöglicht die Auswertung der Glukosewerte hinsichtlich verschiedener Parameter wie Hypo- und Hyperglykämien, Zeit im Zielbereich (Time in Range – TIR), Glukosevariabilität, Glukosestabilität und Glucose Exposure. Des Weiteren ermöglicht es eine einfache und verständliche Interpretation des glykämischen Profils. Sich daraus ergebende Therapie- und Verhaltensanpassungen können die glykämische Kontrolle von Menschen mit Diabetes verbessern. Die vorliegenden praxisnahen Empfehlungen zur Auswertung des AGP stellen eine Expertenmeinung dar, die von praxisnahen Diabetologen erstellt wurde. Anhand von Beispielen und Empfehlungen wird das Vorgehen schrittweise erläutert und zusammengefasst.

Abstract

Continuous glucose monitoring results in high amounts of data that can be summarized and visualized in a standardized manner using the ambulatory glucose profile (AGP). AGP enables the analysis of hypo- and hyperglycemia, time in range (TIR), glucose variability, glucose stability and glucose exposure. It allows an easy and understandable interpretation of the glycemic profile. The resulting changes in treatment and behavior may improve the patients’ glycemic control. The present practical recommendations for the evaluation of the AGP represent an expert opinion provided by practical diabetologists. Using examples and recommendations, the procedure is explained step-by-step and summarised.

Schlüsselwörter

AGP - Expertenempfehlung - Ambulantes Glukoseprofil - Time in Range - Flash-Glukosemonitoring - kontinuierliches Glukosemonitoring

Key words

AGP - expert recommendation - ambulatory glucose profile - time in range - flash glucose monitoring - continuous glucose monitoring
 

  • Literatur

  • 1 Mazze RS, Lucido D, Langer O. et al. Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care 1987; 10: 111-117
    CrossrefPubMedGoogle Scholar
  • 2 Mazze RS, Strock E, Wesley D. et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technology & Therapeutics 2008; 10: 149-159
    CrossrefPubMedGoogle Scholar
  • 3 Bergenstal RM, Ahmann AJ, Bailey T. et al. Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile. Journal of Diabetes Science and Technology 2013; 7: 562-578
    CrossrefPubMedGoogle Scholar
  • 4 Matthaei S. Assessing the value of the Ambulatory Glucose Profile in clinical practice. The British Journal of Diabetes and Vascular Disease 2014; 14: 148-152
    Google Scholar
  • 5 Matthaei S, Dealaiz RA, Bosi E. et al. Consensus recommendations for the use of Ambulatory Glucose Profile in clinical practice. The British Journal of Diabetes and Vascular Disease 2014; 14: 153-157
    Google Scholar
  • 6 Siegmund T, Matthaei S, Reuter M. et al. Ambulantes Glukoseprofil (AGP): Empfehlungen zum Einsatz in der klinischen Praxis. Diabetes Stoffwechsel und Herz 2015; 24: 115-120
    Google Scholar
  • 7 Dunn TC, Crouther N. Assessment of the variance of the ambulatory glucose profile over 3 to 20 days of continuous glucose monitoring. Diabetologia 2010; 53: 421
    Google Scholar
  • 8 Mazze RS, Strock ES, Bergenstal RM. et al. Characterization of Glucose Metabolism. In: Staged Diabetes Management. Wiley-Blackwell; 2011: 29-39
    CrossrefGoogle Scholar
  • 9 Evans M, Cranston I, Bailey CJ. Amulatory glucose profile (AGP): utility in UK clinical practice. The British Journal of Diabetes 2017; 17: 28-33
    Google Scholar
  • 10 Danne T, Nimri R, Battelino T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-1640
    CrossrefPubMedGoogle Scholar
  • 11 Agiostratidou G, Anhalt H, Ball D. et al. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017; 40: 1622-1630
    CrossrefPubMedGoogle Scholar
  • 12 Gandhi GY, Kovalaske M, Kudva Y. et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol 2011; 5: 952-965
    PubMedGoogle Scholar
  • 13 Sartore G, Chilelli NC, Burlina S. et al. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta diabetologica 2012; 49 (Suppl. 01) S153-S160
    PubMedGoogle Scholar
  • 14 Beck RW, Hirsch IB, Laffel L. et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1378-1383
    CrossrefPubMedGoogle Scholar
  • 15 O’Connell MA, Donath S, O’Neal DN. et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009; 52: 1250-1257
    CrossrefPubMedGoogle Scholar
  • 16 Group TJDRFCGMS. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. New England Journal of Medicine 2008; 359: 1464-1476
    CrossrefPubMedGoogle Scholar
  • 17 Holman RR, Paul SK, Bethel MA. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine 2008; 359: 1577-1589
    CrossrefPubMedGoogle Scholar
  • 18 Shafiee G, Mohajeri-Tehrani M, Pajouhi M. et al. The importance of hypoglycemia in diabetic patients. Journal of diabetes and metabolic disorders 2012; 11: 1-7
    PubMedGoogle Scholar
  • 19 International Hypoglycaemia Study Group. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017; 40: 155-157
    CrossrefPubMedGoogle Scholar
  • 20 Karter AJ, Ackerson LM, Darbinian JA. et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. The American journal of medicine 2001; 111: 1-9
    PubMedGoogle Scholar
  • 21 Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008; 51: 365-371
    CrossrefPubMedGoogle Scholar
  • 22 Lin CC, Li CI, Yang SY. et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. The American journal of medicine 2012; 125: 416.e419-418
    Google Scholar
  • 23 Hanefeld M, Fischer S, Julius U. et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583
    CrossrefPubMedGoogle Scholar
  • 24 Monnier L, Colette C. Glycemic variability: should we and can we prevent it?. Diabetes Care 2008; 31 (Suppl. 02) S150-S154
    CrossrefPubMedGoogle Scholar
  • 25 DeVries JH. Glucose Variability: Where It Is Important and How to Measure It. Diabetes 2013; 62: 1405-1408
    CrossrefPubMedGoogle Scholar
  • 26 Monnier L, Colette C, Wojtusciszyn A. et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care 2017; 40: 832-838
    CrossrefPubMedGoogle Scholar
  • 27 Marks V. Glycaemic stability in healthy subjects: fluctuations in blood glucose concentration during the day. In: Andreani D, Marks V, Lefèbvre P. Hrsg Hypoglycemia. New York: Raven Press; 1987: 19-24
    Google Scholar
  • 28 Thomas L. Labor und Diagnose. 8. Auflage.. Aufl: TH-Books Verlagsgesellschaft mbH; 2012
    Google Scholar
  • 29 Distiller LA, Cranston I, Mazze R. First Clinical Experience with Retrospective Flash Glucose Monitoring (FGM) Analysis in South Africa: Characterizing Glycemic Control with Ambulatory Glucose Profile. Journal of Diabetes Science and Technology 2016; 10: 1294-1302
    CrossrefPubMedGoogle Scholar
  • 30 Matthews JN, Altman DG, Campbell MJ. et al. Analysis of serial measurements in medical research. BMJ (Clinical research ed) 1990; 300: 230-235
    CrossrefPubMedGoogle Scholar
  • 31 Omar AS, Salama A, Allam M. et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiology 2015; 15: 14
    CrossrefPubMedGoogle Scholar
  • 32 Rickels MR, Peleckis AJ, Markmann E. et al. Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes. The Journal of clinical endocrinology and metabolism 2016; 101: 4421-4430
    CrossrefPubMedGoogle Scholar